Ashok Sebastian Komaranchath: Delighted to Speak at the 5th International Oncology Forum on 20–21 June 2026
oncodaily - Ashok Sebastian Komaranchath, Consultant Medical Oncology and Clinical Lead for Oncology Services at Burjeel Cancer Institute, Oman, shared on LinkedIn: “I was delighted to speak at the 5th International Oncology Forum […]
AI Summary: The FDA (and HHS) launched Operation TrialBlazer, an initiative to accelerate and modernize clinical development by streamlining trial design, data sharing and regulatory pathways. The program aims to reclaim trial competitiveness and reduce time‑to‑market, promising faster patient access — if stakeholders can agree on what “modernize” actually means.
Related Stories
FDA advances real‑time clinical trials with landmark research collaboration / 1 month
FDA clears AstraZeneca’s new blood-pressure drug baxdrostat / 5 wks
FDA escalates push to withdraw Amgen’s Tavneos; Amgen updates label / 7 wks
FDA links eight deaths to Amgen’s Tavneos; scrutiny intensifies / 2 months
Denali drug receives accelerated approval for rare CNS indication / 2 months
FDA launches individualized therapy framework for ultra-rare diseases / 4 months
FDA makes one pivotal trial the default for drug approvals / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Oncology, Eli Lilly, Infant Health, Corporate Takeover and look for the RSS link.
StackHealth Time Machine